# U03 CD-08 Execution Authorization Review v0.1

> 对象：CD-08 post-implementation clinical validation readiness package 的独立执行授权审查。  
> 审查输入 HEAD：`b422e675deddbffdc59b3acabdb8fe01c96aeb2b`。  
> Base：`prep/u03-cd07-implementation-readiness@aaf733d9a032840a63c24d15afe762dd31ffdc0e`。  
> 审查角色：`U03_TECHNICAL_GOVERNANCE_REVIEW`。  
> 日期：`2026-09-17`。  
> 状态：`AUTHORIZATION_REVIEW_COMPLETE / AUTHORIZED / NON_PRODUCTION_VALIDATION_ONLY / NOT_CLINICAL_APPROVAL / NOT_PRODUCTION / NOT_U04 / NOT_MERGE`。

## 1. Review scope

本审查只回答：现有 CD-08 readiness package 是否足以约束一个独立的 non-production post-implementation clinical validation execution。

不重新裁定：

```text
Gate A / B / C
Gate-C clinical expected outcomes
CD-07 implementation review / merge authorization / PMV
Medical/Clinical Owner 对最终 CD-08 临床证据的独立判定
```

## 2. Change isolation

PR #92 在授权输入 HEAD 前只包含 5 个新增治理文档：

```text
U03_CD08_Sequence_Reconciliation_v0.1.md
U03_CD08_Scope_Authorization_Boundary_v0.1.md
U03_CD08_Post_Implementation_Clinical_Validation_Protocol_v0.1.md
U03_CD08_Validation_Evidence_Requirements_v0.1.md
U03_CD08_Readiness_Assessment_v0.1.md
```

```text
runtime code changes = 0
workflow changes = 0
Gate-C fixture changes = 0
clinical rule / threshold / expected-outcome changes = 0
```

## 3. Mandatory authorization questions

| ID | Question | Verdict |
|---|---|---|
| A8-01 | CD-08 validation target 是否明确为实际 CD-07 runtime | APPROVE |
| A8-02 | Gate-C exact EvalSet / release set 是否冻结 | APPROVE |
| A8-03 | Golden/Safety accounting 与 excluded identities 是否固定 | APPROVE |
| A8-04 | case-level clinical comparison 与 evidence schema 是否明确 | APPROVE |
| A8-05 | discrepancy 是否禁止开发者自行重写 clinical truth | APPROVE |
| A8-06 | production / real-patient / U04 / new semantics 是否明确排除 | APPROVE |
| A8-07 | final CD-08 PASS 是否仍要求独立 clinical/governance evidence review | APPROVE |

```text
blocking authorization findings = 0
```

## 4. Authorization

```text
Authorization ID = AUTH-U03-CD08-CLINVAL-EXEC-001
Status = AUTHORIZED
Mode = NON_PRODUCTION_VALIDATION_ONLY
```

授权仅允许开新的 isolated implementation/execution branch / PR，完成 CD-08 所需的验证适配、workflow、case-level evidence capture 与受控 non-production execution。

### 4.1 Bound readiness package

```text
readiness PR = #92
readiness reviewed HEAD = b422e675deddbffdc59b3acabdb8fe01c96aeb2b
base = aaf733d9a032840a63c24d15afe762dd31ffdc0e
```

绑定：

```text
R8-1 U03_CD08_Sequence_Reconciliation_v0.1.md
R8-2 U03_CD08_Scope_Authorization_Boundary_v0.1.md
R8-3 U03_CD08_Post_Implementation_Clinical_Validation_Protocol_v0.1.md
R8-4 U03_CD08_Validation_Evidence_Requirements_v0.1.md
U03_CD08_Readiness_Assessment_v0.1.md
```

### 4.2 Exact governed set

只允许：

```text
ER-U03-RISK-001@0.1.0-candidate
KR-U03-SOURCE-001@0.1.0-candidate
RR-U03-RISK-001@0.2.1-candidate
U03_D09_COVERAGE_V0_2_1_CANDIDATE
PR-U03-D09-001@0.2.1-candidate
PF-U03-C-POLICY-001
```

### 4.3 Authorized execution scope

```text
C8-01  run executable Golden cases through actual CD-07 non-production runtime
C8-02  run executable critical Safety cases through actual CD-07 non-production runtime
C8-03  capture expected-vs-actual clinical outcomes
C8-04  capture C02/D09/evidence/release/state/proposal/commit/trace correlation
C8-05  verify committed semantic state where commit occurs
C8-06  verify failure/missingness/scope distinctions
C8-07  verify replay/idempotency behavior where governed fixtures require it
C8-08  generate durable machine-readable and human-readable evidence
C8-09  implement only validation adapters/workflow required for the above
C8-10  remediate validation-engineering defects without changing clinical truth
```

## 5. Explicitly not authorized

```text
- changing Gate-C expected clinical outcomes
- changing Rule/Policy/Knowledge/EvalSet semantics
- adding clinical rules/thresholds/disposition vocabulary
- release publication or production activation
- production Clinical State mutation
- real-patient traffic
- external production API wiring
- U04 Safety Gate implementation / owner execution / routing
- U14 routing
- pediatrics / pregnancy-puerperium / China production expansion
- declaring CD-08 PASS without independent clinical/governance evidence review
- declaring U03 Clinical Dependency Closure before CD-08 formal PASS
```

## 6. Required execution safeguards

Implementation/execution must prove:

```text
- exact implementation/test SHA identity
- explicit non-production environment
- no real-patient traffic
- exact release binding; no latest/current aliases
- actual CD-07 runtime path rather than evaluation-only harness substitution
- case-level denominator integrity
- GC-026 and SS-012 remain explicit excluded unless separately re-governed
- no failed/missing technical state is flattened into safe/normal/low-risk clinical truth
- no U04 owner logic executes
```

## 7. Required post-execution sequence

```text
isolated CD-08 implementation/execution PR
↓
formal execution + durable evidence freeze
↓
independent implementation/evidence review
↓
independent clinical/governance evidence review
↓
if findings: remediation + re-execution
↓
formal CD-08 decision
↓
if PASS: U03 Clinical Dependency Closure review
↓
only after closure: U04 readiness re-review
```

No execution result self-authorizes merge, clinical approval, U04, or production.

## 8. Decision

```text
A8-01..07 = APPROVE
blocking authorization findings = 0

AUTH-U03-CD08-CLINVAL-EXEC-001
= AUTHORIZED / NON_PRODUCTION_VALIDATION_ONLY

CD-08 Readiness
= PASS / CONSUMED_BY_EXECUTION_AUTHORIZATION

CD-08 Execution
= AUTHORIZED_TO_START_ON_ISOLATED_BRANCH

CD-08 Clinical Validation
= NOT_YET_PASSED

U03 Clinical Dependency Closure
= NOT_COMPLETE / BLOCKED_BY_CD08

U04 Readiness
= DEFERRED_UNTIL_CD08_CLOSURE

U04 Implementation Authorization
= NOT_GRANTED

Clinical Runtime Production
= NOT_ENABLED
Production Authorization
= BLOCKED
```
